Protalix Biotherapeutics Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Protalix Biotherapeutics Inc with three other
companies in this sector in UNITED STATES :
Twist Bioscience Corp
sales of $54.39 million
of which 40%
was Industrial chemicals),
Apollo Endosurgery Inc
of which 56%
was Endo bariatric-ESS), and
PDL Biopharma, Inc.
of which 101%
During the year ended December of 2019, sales at
Protalix Biotherapeutics Inc were $54.69 million.
increase of 59.7%
versus 2018, when the company's sales were $34.24 million.
This was the fourth straight year of sales growth at Protalix Biotherapeutics Inc.